ATR and cancer: In summary, our data identify a novel p53-independent nucleolar stress pathway that senses perturbations in rDNA chromatin structure and dynamics leading to activation of ATM/ATR signaling and a prompt halt in cell cycle progression and provide a rationale for clinical evaluation of combining DDR pathway inhibitors with CX-5461 to treat in p53-null cancers.